In thyroid tumors, RAS gene mutations can persistently activate the PI3K/AKT signaling pathway, thereby enhancing glycolytic flux and promoting the membrane localization of glucose transporter protein (GLUT1), which increases glucose uptake capacity. This evidence concerns the gene AKT1 and thyroid tumor.